1. Toxicokinetics in preclinical evaluation;Baldrick;Drug Discovery Today,2003
2. Toxicogenomics: a new revolution in drug safety;Castle;Drug Discovery Today,2002
3. Points to consider for the assessment of the potential QT prolongation by non-cardiovascular medicinal products. Publication CPMP 986/96;Committee for Proprietary Medicinal Products,1997
4. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity;De Clerck;Fundamental and Clinical Pharmacology,2002